Warrant Confirmation Amendment Agreement (May 10th, 2011)
THIS WARRANT CONFIRMATION AMENDMENT AGREEMENT (this Agreement) dated as of May 4, 2011 is between Core Laboratories N.V. (Issuer) and Citibank, N.A. (Dealer). Unless otherwise defined herein, each capitalized term used herein shall have the meaning assigned to such term in the Confirmation referred to below.
Amendment No. 1 to Credit Agreement (April 21st, 2011)
This Amendment No. 1 to Credit Agreement (this "Amendment"), dated as of April 19, 2011 (the "Effective Date"), is entered into among CORE LABORATORIES N.V., a Netherlands limited liability company, (the "Parent"), and CORE LABORATORIES LP, a Delaware limited partnership (the "US Borrower" and, together with the Parent, the "Borrowers" and, each a "Borrower"), the lenders party to the Credit Agreement described below, and BANK OF AMERICA, N.A., as Administrative Agent (in such capacity, the "Administrative Agent"), Swing Line Lender and L/C Issuer.
Re: Warrant Transaction Amendment (November 20th, 2006)
This letter agreement (the "Amendment") amends the terms and conditions of the Transaction (the "Transaction") entered into between Lehman Brothers OTC Derivatives Inc. ("Dealer") represented by Lehman Brothers Inc. ("Agent") as its agent, and Core Laboratories N.V. ("Issuer"), pursuant to a letter agreement dated October 31, 2006 (the "Confirmation"), pursuant to which Dealer purchased from Issuer a Number of Warrants equal to 2,683,325. This Amendment relates to, and sets forth the terms of, the purchase by Dealer from Issuer of an additional Number of Warrants (the "Additional Number of Warrants").
REGISTRATION RIGHTS AGREEMENT Dated as of November 6, 2006 by and Among CORE LABORATORIES LP, as Issuer, CORE LABORATORIES N.V. As Guarantor and the Initial Purchasers Party Hereto 0.25% Senior Exchangeable Notes Due 2011 (November 6th, 2006)
This Registration Rights Agreement (the Agreement) is made as of November 6, 2006 by and among Core Laboratories LP, a Delaware limited partnership (the Company), Core Laboratories N.V., a Netherlands limited liability company (the Guarantor) and Lehman Brothers Inc. and Banc of America Securities LLC, acting on behalf of the several parties (the Initial Purchasers) named in Schedule A to that certain Purchase Agreement, dated October 31, 2006 (as it may be amended from time to time, the Purchase Agreement), by and among the Company, the Guarantor and Lehman Brothers Inc. and Banc of America Securities LLC as representatives of the Initial Purchasers.
CORE LABORATORIES LP, as Issuer CORE LABORATORIES N.V., as Guarantor 0.25% SENIOR EXCHANGEABLE NOTES DUE 2011 INDENTURE Dated as of November 6, 2006 WELLS FARGO BANK, NATIONAL ASSOCIATION as Trustee (November 6th, 2006)
* Note: This Cross Reference Table shall not, for any purpose, be deemed to be part of the Indenture ** Note: N.A. means Not Applicable.
Core Laboratories Lp .25% Senior Exchangeable Notes Due 2011 Guaranteed by Core Laboratories N.V. Purchase Agreement (November 6th, 2006)
Core Laboratories, LP, a Delaware limited partnership (the Company), proposes to issue and sell to the initial purchasers listed on Schedule A hereto (the Initial Purchasers) for whom you are the representatives $250,000,000 principal amount of its .25% Exchangeable Notes Due 2011 (the Firm Notes) to be issued pursuant to the provisions of an Indenture to be dated as of November 6, 2006 (the Indenture) among the Company, the Guarantor (as defined below) and Wells Fargo Bank, National Association as Trustee (the Trustee). The Company also proposes to issue and sell to the Initial Purchasers not more than an additional $50,000,000 principal amount of its .25% Senior Exchangeable Notes Due 2011, solely to cover over-allotments (the Additional Notes) if and to the extent the Initial Purchasers elect to exercise the right to purchase such Additional Notes granted to the Initial Purchasers in Section 2 hereof. The Firm Notes and the Additional Notes, together with the Guarantees (as defined